First Successful Bloodless Combined Heart‐Liver Transplantation in a Jehovah's Witness
Clinical Transplantation · 2026-06 · 40 (6)
DOI: 10.1111/ctr.70592 ↗At a glance
Fallbericht in Clinical Transplantation, published online on 2026-06-12. Written by Chamanthi Konidala and 10 co-authors. Institution: University of South Florida Morsani College of Medicine, Tampa, Florida, USA. Major MEDLINE topics: Jehovah's Witnesses, Liver Transplantation, Heart Transplantation, Bloodless Medical and Surgical Procedures. 12 references. Funded by: University of South Florida.
Abstract (original language)
Background
Combined heart‐liver transplantation (CHLT) represents an infrequent and highly intricate surgical intervention characterized by substantial risk. While isolated cases documenting bloodless heart transplantation or transfusion‐free liver transplantation exist, a successful bloodless CHLT had not previously been recorded. This case report details the inaugural instance of such a procedure performed for a Jehovah's Witness patient. Case Presentation A 67‐year‐old male Jehovah's Witness with severe multi‐vessel coronary artery disease and refractory angina, heart failure with preserved ejection fraction, and metabolic dysfunction‐associated steatohepatitis (MASH)‐related cirrhosis (stage III–IV) was admitted for transplant evaluation at Tampa General Hospital. Listed as UNOS Status 2e, he underwent bloodless CHLT. Preoperative hemoglobin was 15 g/dL, and platelet count was 157 000/µL, optimized with erythropoietin and iron supplementation. Intraoperative blood conservation strategies included meticulous surgical techniques, acute normovolemic hemodilution (ANH, two units), cell salvage (675 mL), cryoprecipitate (600 mL), aminocaproic acid, and FEIBA (factor eight inhibitor bypassing activity). Both transplantations were uneventful. The patient was extubated on postoperative day 1 (POD 1). Endomyocardial biopsy on POD 16 showed no rejection. An echocardiogram on POD 18 confirmed preserved biventricular function (LVEF 60–65%). The patient was discharged on POD 24 with hemoglobin of 9.6 g/dL and platelet count of 227 000/µL. At POD 60, he exhibited excellent function of both transplanted organs.
Conclusions
This report expands the scope of bloodless medicine, offering a model for managing complex multi‐organ transplants in patients with religious restrictions to blood products, with the patient continuing to exhibit excellent recovery approximately ten months post‐transplant.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- University of South Florida Morsani College of Medicine, Tampa, Florida, USA.
- Department of Anesthesiology and Perioperative Medicine, University of South Florida Morsani College of Medicine, Tampa, Florida, USA.
- Anesthesia, TeamHealth, Knoxville, Tennessee, USA.
- Department of Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida, USA.
Funding
- University of South Florida
Cite
APA
Konidala, C., Perrone, J., Miranda, C., Balazs, Z., Hill, J., Weiss, J., Jalil, T., Katlaps, G., Dhanireddy, K., Elia, E., & Camporesi, E. (2026). First Successful Bloodless Combined Heart‐Liver Transplantation in a Jehovah's Witness. Clinical Transplantation, 40(6). https://doi.org/10.1111/ctr.70592
Vancouver
Konidala C, Perrone J, Miranda C, Balazs Z, Hill J, Weiss J, et al. First Successful Bloodless Combined Heart‐Liver Transplantation in a Jehovah's Witness. Clinical Transplantation. 2026;40(6). doi:10.1111/ctr.70592
BibTeX
@article{Konidala2026,
author = {Konidala, Chamanthi and Perrone, Juan and Miranda, Carlos and Balazs, Zsolt and Hill, Jenna and Weiss, Jeffrey and Jalil, Tanjina and Katlaps, Gundars and Dhanireddy, Kiran and Elia, Elia and Camporesi, Enrico},
title = {First Successful Bloodless Combined Heart‐Liver Transplantation in a Jehovah's Witness},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {6},
doi = {10.1111/ctr.70592}
}
EUVIMED